Your browser doesn't support javascript.
loading
Neprilysin inhibition for pulmonary arterial hypertension: a randomized, double-blind, placebo-controlled, proof-of-concept trial.
Hobbs, Adrian J; Moyes, Amie J; Baliga, Reshma S; Ghedia, Dipa; Ochiel, Rachel; Sylvestre, Yvonne; Doré, Caroline J; Chowdhury, Kashfia; Maclagan, Kate; Quartly, Harriet L; Sofat, Reecha; Smit, Angelique; Schreiber, Benjamin E; Coghlan, Gerry J; MacAllister, Raymond J.
Afiliación
  • Hobbs AJ; William Harvey Research Institute, Barts and The London School of Medicine and Dentistry, Queen Mary University of London, London, UK.
  • Moyes AJ; William Harvey Research Institute, Barts and The London School of Medicine and Dentistry, Queen Mary University of London, London, UK.
  • Baliga RS; William Harvey Research Institute, Barts and The London School of Medicine and Dentistry, Queen Mary University of London, London, UK.
  • Ghedia D; Department of Cardiology, Royal Free London NHS Foundation Trust, London, UK.
  • Ochiel R; Department of Cardiology, Royal Free London NHS Foundation Trust, London, UK.
  • Sylvestre Y; Comprehensive Clinical Trials Unit, University College London, London, UK.
  • Doré CJ; Comprehensive Clinical Trials Unit, University College London, London, UK.
  • Chowdhury K; Comprehensive Clinical Trials Unit, University College London, London, UK.
  • Maclagan K; Comprehensive Clinical Trials Unit, University College London, London, UK.
  • Quartly HL; Comprehensive Clinical Trials Unit, University College London, London, UK.
  • Sofat R; Centre for Clinical Pharmacology, Rayne Institute, London, UK.
  • Smit A; Department of Cardiology, Royal Free London NHS Foundation Trust, London, UK.
  • Schreiber BE; Department of Cardiology, Royal Free London NHS Foundation Trust, London, UK.
  • Coghlan GJ; Department of Cardiology, Royal Free London NHS Foundation Trust, London, UK.
  • MacAllister RJ; Dorset County Hospital NHS Foundation Trust, Dorset, UK.
Br J Pharmacol ; 176(9): 1251-1267, 2019 05.
Article en En | MEDLINE | ID: mdl-30761523
Asunto(s)
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Contexto en salud: 1_ASSA2030 / 2_ODS3 Problema de salud: 1_doencas_nao_transmissiveis / 2_muertes_prematuras_enfermedades_notrasmisibles Asunto principal: Neprilisina / Hipertensión Arterial Pulmonar Tipo de estudio: Clinical_trials Límite: Adolescent / Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Revista: Br J Pharmacol Año: 2019 Tipo del documento: Article País de afiliación: Reino Unido
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Contexto en salud: 1_ASSA2030 / 2_ODS3 Problema de salud: 1_doencas_nao_transmissiveis / 2_muertes_prematuras_enfermedades_notrasmisibles Asunto principal: Neprilisina / Hipertensión Arterial Pulmonar Tipo de estudio: Clinical_trials Límite: Adolescent / Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Revista: Br J Pharmacol Año: 2019 Tipo del documento: Article País de afiliación: Reino Unido